• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL0500026 重组人CD22单克隆抗体注射液 Recombinant anti-CD22 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2005-04-01 深圳龙瑞药业有限公司 Lonn Ryonn PHARMA Ltd Certificate Issued 2006-08-24 view
CXSL0500025 重组人CD22单克隆抗体注射液 Recombinant anti-CD22 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2005-04-01 深圳龙瑞药业有限公司 Lonn Ryonn PHARMA Ltd Certificate Issued 2006-08-24 view
CXSL0600048 重组人CD22单克隆抗体注射液 Recombinant anti-CD22 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2006-10-23 深圳龙瑞药业有限公司 Lonn Ryonn PHARMA Ltd Certificate Issued 2008-12-22 view
CXSL0600064 重组人CD22单克隆抗体注射液 Recombinant anti-CD22 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2007-01-22 深圳龙瑞药业有限公司 Lonn Ryonn PHARMA Ltd Certificate Issued 2008-03-24 view
CXSB0900032 重组人CD22单克隆抗体注射液 Recombinant anti-CD22 humanized monoclonal antibody Injection Biological Products Supplementary Application 2010-01-08 深圳龙瑞药业有限公司 Lonn Ryonn PHARMA Ltd Certificate Issued 2010-11-23 view